skip to Main Content

Now with over 4,200 members from all over the world, EASL is an influential international organisation. It attracts the foremost hepatology experts as members and has an impressive track record in promoting research in liver disease, supporting wider education, and promoting changes in European liver policy.

Leadership & Governance

Ethics Committee

The role of the Ethics Committee will be to review the membership of the panels which author EASL’s Clinical Practice Guidelines to eliminate the potential for real or perceived bias which might undermine the integrity of the guidelines. The Ethics Committee will agree on guidelines for reviewing appointments to the Clinical Practice Guideline panels. Candidate membership of the panels will be proposed by the Governing Board for approval by the Ethics Committee according to these guidelines.

The Ethics Committee consists of five members who will be independent of the Governing Board membership. One member, elected by the Ethics Committee, will perform the role of the chair. Members will serve for three years. The first members of the Ethics Committee will be proposed by the Governing Board for approval by the General Assembly. New members will be proposed by the Ethics Committee for approval by the General Assembly. The Ethics Committee will meet once each year at the International Liver Congress™ and as needed.

Prof. Christian Trautwein

EASL Ethics Committee Chairperson

Prof. Marina Berenguer

La Fe University and Polytechnic Hospital, Valencia, Spain

Prof. Valérie Paradis

Hôpital Beaujon, AP-HP, Clichy, France

Prof. Mark Thursz

Imperial College London, United Kingdom

Prof. Herbert Tilg

Medical University Innsbruck, Austria
Back To Top